As an organization that serves young women affected by breast cancer, we make sure to keep up with the latest news so we know what our women face when it comes to treatment and beyond. In this blog series, we will share the month’s news that we feel is most interesting and relevant.
July 6: Based on recent studies over the past decade, the old warnings about how breast cancer survivors should avoid the complication of lymphedema (which can cause irreversible swelling in the arm and often hardening of skin) have been dramatically relaxed. Read the full article in the Washington Post here to find out what experts are now recommending about this health issue.
July 9: Researchers found that non-Hispanic black women were more than twice as likely as white women to be diagnosed with so-called triple-negative breast cancers, while women under 40 were nearly twice as likely to be diagnosed with the aggressive cancer as those aged 50 to 64, according to the study published in Cancer. Read the complete article in Reuters here.
July 10: Using data from a person’s immune response, researchers have devised a blood test that may accurately predict the risk of breast cancer recurrence. The goal is for physicians and breast cancer patients to know the risk of the disease recurring within the next 3–5 years. Read the full article on Medical News Today here.
July 24: Following a request from the Food and Drug Administration, Allergan is recalling its textured breast implants worldwide. The move comes after 38 countries already recalled the implant because of the higher risk of anaplastic large cell lymphoma, or BIA-ALCL, a cancer of the immune system. Read more or watch a video on NBC.com here.